SCHEMBL3450464

SCHEMBL3450464

CN1CCC(N2CCN(C(=O)CN3CCCC(N)C3)CC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 4/20 0.44
L3MBTL3 Q96JM7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GAA P10253 2/20 0.41
LMNA P02545 1/20 0.41
F10 P00742 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
BIRC2 Q13490 1/20 0.38
ACHE P22303 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
RECQL P46063 1/20 0.36
CHRM5 P08912 2/20 0.34
CHRM1 P11229 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM3 P20309 1/20 0.34
F2 P00734 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3448427 0.92 ALDH1A1 (0.43) ALDH1A1KDM4EL3MBTL3L3MBTL1GAA
SCHEMBL3450967 0.92 ALDH1A1 (0.43) ALDH1A1KDM4EL3MBTL3L3MBTL1GAA
SCHEMBL24802129 0.81 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL3L3MBTL1GAA
SCHEMBL24204406 0.79 ALDH1A1 (0.45) ALDH1A1KDM4EL3MBTL3L3MBTL1GAA
SCHEMBL29307355 0.76 GAA (0.44) ALDH1A1KDM4EGAALMNAMEN1
SCHEMBL3766167 0.76 SIGMAR1 (0.50) ALDH1A1KDM4EL3MBTL3L3MBTL1GAA
SCHEMBL24352086 0.76 ALDH1A1 (0.45) ALDH1A1KDM4EL3MBTL3L3MBTL1GAA
SCHEMBL4678853 0.74 L3MBTL3 (0.50) ALDH1A1KDM4EL3MBTL3L3MBTL1F10
SCHEMBL3766239 0.74 KDM4E (0.51) ALDH1A1KDM4EGAALMNASMN1; SMN2
SCHEMBL21281275 0.73 KDM4E (0.65) ALDH1A1KDM4EL3MBTL3L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820699-B2 Cyclic amines HOFFMANN-LA ROCHE INC. (US) 2010-10-26 US disclosed
US-20060247238-A1 Cyclic amines F. HOFFMANN-LA ROCHE AG (CH) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247238-A1 Cyclic amines F12, F11, F2 ALDH1A1 2056/4885KDM4E 2242/4885L3MBTL3 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.